Ritholtz Wealth Management’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q2 | – | Sell |
-3,500
| Closed | -$270K | – | 511 |
|
2021
Q1 | $270K | Buy |
+3,500
| New | +$270K | 0.02% | 337 |
|
2020
Q4 | – | Sell |
-7,000
| Closed | -$301K | – | 385 |
|
2020
Q3 | $301K | Sell |
7,000
-3,200
| -31% | -$138K | 0.03% | 209 |
|
2020
Q2 | $422K | Buy |
10,200
+1,200
| +13% | +$49.6K | 0.05% | 129 |
|
2020
Q1 | $389K | Buy |
9,000
+1,000
| +13% | +$43.2K | 0.06% | 90 |
|
2019
Q4 | $443K | Hold |
8,000
| – | – | 0.06% | 89 |
|
2019
Q3 | $278K | Sell |
8,000
-11,409
| -59% | -$396K | 0.05% | 110 |
|
2019
Q2 | $782K | Hold |
19,409
| – | – | 0.13% | 53 |
|
2019
Q1 | $639K | Buy |
19,409
+5,000
| +35% | +$165K | 0.12% | 64 |
|
2018
Q4 | $299K | Buy |
+14,409
| New | +$299K | 0.07% | 95 |
|